These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31610026)
1. A Leishmania donovani dominant-negative mutant for eIF2α kinase LdeK1 elicits host-protective immune response. Jha MK; Rao SJ; Sarode AY; Saha B; Kar A; Pal JK Parasite Immunol; 2020 Jan; 42(1):e12678. PubMed ID: 31610026 [TBL] [Abstract][Full Text] [Related]
2. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity. Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522 [TBL] [Abstract][Full Text] [Related]
3. A GCN2-Like eIF2α Kinase (LdeK1) of Leishmania donovani and Its Possible Role in Stress Response. Rao SJ; Meleppattu S; Pal JK PLoS One; 2016; 11(6):e0156032. PubMed ID: 27248816 [TBL] [Abstract][Full Text] [Related]
8. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275 [TBL] [Abstract][Full Text] [Related]
9. Mevalonate kinase of Leishmania donovani promotes its survival and plays a pivotal role in pathogenesis. Shafi MT; Bamra T; Roy C; Kumar M; Das P Exp Parasitol; 2024; 263-264():108800. PubMed ID: 39043326 [TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis. Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164 [TBL] [Abstract][Full Text] [Related]
11. Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice. Gupta G; Majumdar S; Adhikari A; Bhattacharya P; Mukherjee AK; Majumdar SB; Majumdar S Med Microbiol Immunol; 2011 Nov; 200(4):241-53. PubMed ID: 21533785 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077 [TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis. Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125 [TBL] [Abstract][Full Text] [Related]
15. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo. Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084 [TBL] [Abstract][Full Text] [Related]
17. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T; Anam K; Ali N Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis. Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606 [TBL] [Abstract][Full Text] [Related]
19. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection. Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430 [TBL] [Abstract][Full Text] [Related]
20. Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host. Rouault E; Lecoeur H; Meriem AB; Minoprio P; Goyard S; Lang T Parasitol Int; 2017 Feb; 66(1):933-939. PubMed ID: 27794505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]